ST Jingfeng: Expected net profit to be negative in 2025.

*ST Jingfeng announced that it is expected to have a negative net profit in 2025, with an estimated net loss of -90 million to -60 million. In 2025, due to the impact of pharmaceutical industry policies, the selling prices of the company's main products have slightly decreased, and sales have not shown a clear recovery trend, resulting in the company still being in an operational loss state in 2025.*